|
|
Volumn 297, Issue 5585, 2002, Pages 1262-1263
|
|
Protecting the brain while killing pain?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DISEASES;
DRUG PRODUCTS;
EPIDEMIOLOGY;
RISKS;
ANALGESICS;
BRAIN;
AMYLOID BETA PROTEIN;
CELECOXIB;
CYCLOOXYGENASE 2 INHIBITOR;
NAPROXEN;
NONSTEROID ANTIINFLAMMATORY AGENT;
PLACEBO;
PROSTAGLANDIN SYNTHASE INHIBITOR;
ROFECOXIB;
AMYLOID BETA PROTEIN (1 42);
AMYLOID BETA-PROTEIN (1-42);
PEPTIDE FRAGMENT;
PYRAZOLE DERIVATIVE;
SULFONAMIDE;
DISEASE INCIDENCE;
DISEASE TREATMENT;
EPIDEMIOLOGY;
ALZHEIMER DISEASE;
ARTHRITIS;
BRAIN DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG INDUCED DISEASE;
DRUG MECHANISM;
DRUG PREFERENCE;
GASTROINTESTINAL TOXICITY;
HUMAN;
MAJOR CLINICAL STUDY;
NEUROLOGIC DISEASE;
PRIORITY JOURNAL;
SHORT SURVEY;
ARTICLE;
BRAIN;
CELL CULTURE;
DRUG EFFECT;
METABOLISM;
NERVE CELL;
PATHOLOGY;
ALZHEIMER DISEASE;
AMYLOID BETA-PROTEIN;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
BRAIN;
CELLS, CULTURED;
CONTROLLED CLINICAL TRIALS;
CYCLOOXYGENASE INHIBITORS;
HUMANS;
NAPROXEN;
NEURONS;
PEPTIDE FRAGMENTS;
PYRAZOLES;
SULFONAMIDES;
|
|
EID: 0037162751
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.297.5585.1262 Document Type: Short Survey |
|
Times cited : (10)
|
|
References (0)
|